Defects in the cystic fibrosis transmembrane conductance regulator (CFTR) protein cause cystic fibrosis (CF), an autosomal recessive disease that currently limits the average life expectancy of sufferers to <40 years of age. The development of novel drug molecules to restore the activity of CFTR is an important goal in the treatment CF, and the isolation of functionally active CFTR is a useful step towards achieving this goal.
Introduction
Cystic fibrosis (CF) is the most common genetic disorder in Europe and North America with an incidence of about 1 in 2,500 live births. CF occurs when mutations in the cystic fibrosis transmembrane conductance regulator (CFTR) protein cause loss of its function at the plasma membrane of epithelial cells 1 . The most serious consequence of this defect is irreversible lung damage, which shortens the life expectancy of sufferers to <40 years of age 2, 3 .
CFTR is an ATP-binding cassette (ABC) transporter that has evolved to become an ion channel 1, 4 . Despite its quite altered function in the plasma membrane of cells, it still retains significant sequence homology with other ABC transporters. Intriguingly, the specialized parts of CFTR (i.e. its regulatory region and its N-and C-termini) share no significant sequence similarity with other metazoan ABC transporters, hence there are no clues as to the origins of these sequences in CFTR. On the basis of its primary structure, CFTR is classified as a C-family member of the ABC transporter family, but there is no strong evidence for a residual functional linkage to this sub-family. There have been some reports of glutathione transport activity for CFTR [5] [6] [7] , which would be consistent with the roles of other C-family members 8, 9 , although other reports suggest that reduced glutathione may inhibit the CFTR ATPase activity, rather than showing the substrate-induced stimulation that characterize the ABC transporters 10 . Measurement of ion conductance is sufficiently sensitive to allow the channel activity of single CFTR molecules to be studied 1 and CFTR channel properties have been monitored as a function of time, temperature, ATP concentration, membrane potential, and phosphorylation state, as well as in the presence of a host of small molecule inhibitors, potentiators, and modifiers. These studies have also added significantly to our knowledge of how ABC transporters function. Nevertheless, expression of CFTR in significant amounts and its subsequent purification has proven to be particularly challenging and success has been limited to a few laboratories [10] [11] [12] [13] .
The need to develop more effective drugs is pressing, yet this process has been hindered by the lack of purified CFTR for screening small molecules. Solving the CFTR expression and purification problem would enable high-throughput drug screening aimed at correcting the primary defect in CF and would also open up a route for high-resolution structural studies to inform rational drug design. Moreover, even relatively basic biochemical characteristics of the protein, such as its functional oligomeric state, interacting proteins and ATPase activity remain poorly characterized. We have previously reported a protocol for the large-scale expression of GFP-and His-tagged murine CFTR in S. cerevisiae [15] [16] [17] [18] [19] [20] [21] . The ionic detergent 1-tetradecanoyl-sn-glycero-3-phospho-(1'-rac-glycerol) (LPG-14) is highly efficient in the solubilization of CFTR and has previously been used in the purification of functional membrane proteins 10, 22, 23 , including purification of CFTR from S. cerevisiae 24 .
Protocol

Preparation of Buffers
1. To make the 100x stock of protease inhibitor (PI) cocktail dissolve 96 mg AEBSF, 3.5 mg chymostatin, 10 mg E64, 16.5 mg leupeptin, 16.5 mg pepstatin, 348 mg PMSF, and 4 mg bestatin in 20 ml DMSO. Make 1 ml aliquots and store at -20 °C. To make a 100x stock of benzamidine, dissolve 720 mg in 20 ml ultrapure water (ddH 2 O) and store in 1 ml aliquots at -20 °C. This quantity is sufficient for one purification. In all buffers, PI and benzamidine stocks are used at a 1:100 dilution. , then retain the pellet also. 6. Centrifuge the supernatant from the previous step (200,000 x g, 4 °C, 1.5 hr). Discard the supernatant and resuspend the pelleted microsomal membranes in CFTR buffer. If the microsomes are intended for purification using DDM, supplement the CFTR buffer with 1 M NaCl. 7. Repeat the centrifugation of the resuspended membrane fraction (100,000 x g, 4 °C, 1 hr) and discard the supernatant. 8. Resuspend the pelleted microsomes in a minimum volume of CFTR buffer (final volume 5-15 ml, total microsomal protein 70-200 mg). A Bradford assay may be used to determine the total concentration of microsomal proteins 25 . In addition the fluorescence emission spectrum of the membranes should be measured (excitation = 485 nm, emission = 500-600 nm) and should have a distinct GFP fluorescence peak (maximum at 512 nm). CFTR can be specifically detected on an SDS-PAGE gel, scanned under GFP fluorescence conditions (Figure 1) . 9. Flash-freeze the resuspended microsomes by plunging into liquid nitrogen and store at -80 °C, or continue to Step 3.
The protocol for CFTR purification using DDM gives purity of about 60% and yield of roughly 50 μg/L (Figure 3) . Electron microscopy (EM) of negatively stained fractions from the GPC eluting at about 10 ml (Figure 4) showed that DDM-purified CFTR contains aggregates of 20-30 nm diameter as well as smaller particles of 10 nm diameter (data not shown). It is possible that the small aggregates can reversibly associate and dissociate as ultrafiltration with a 1 MDa cut-off filter failed to remove the EM-detectable aggregates. LPG-purified material did not adsorb to a glowdischarged grid, hence was studied by cryo-EM of unstained fractions. This showed a very homogeneous particle population of a relatively small size (6-8 nm diameter, data not shown).
Finally, the ATPase activity of the purified proteins was measured ( Figure 5) . As a member of the ABC protein family, CFTR has two nucleotidebinding domains (NBDs) capable of binding and/or hydrolyzing ATP. The data indicate that the purified protein was not able to hydrolyze ATP in the LPG-solubilized state and showed weak ATPase activity in the presence of DDM (Figure 5, unfilled bars) . After the addition of lipids, and detergent removal, ATPase activity was 4-fold higher for samples that had been purified in DDM (13 nmol ATP/min/mg protein). The addition of lipids and removal of LPG similarly restored activity to CFTR that had been isolated using LPG, but with a final lower rate (1.5 nmol ATP/min/mg protein) than the DDM-purified and reconstituted material. Monitoring levels of chicken CFTR in cell lysate (CL), supernatants (S) and pellets (P) during various centrifugation steps used for microsome isolation and washing. SDS-PAGE gels were visualized using the in-gel fluorescence of the GFP tag. The supernatant after cell breakage and centrifugation at 14,000 x g contains virtually all the CFTR (including degradation products). Ultracentrifugation at 200,000 x g sediments all the full-length CFTR leaving some fragments in the supernatant. Ultracentrifugation at 100,000 x g of salt-washed microsomes pellets nearly all the CFTR with the removal of some further fragments. in the presence of a cocktail of ATPase inhibitors to eliminate any background ATPase activity from F-, P-and V-type ATPases (unfilled bars). The rate of ATP hydrolysis was also measured after detergent removal and lipid addition (filled bars). The plot shows the mean and standard deviation (n=3). Differences between mean values for ATPase activity in presence and absence of lipid, and difference between activity in DDM and LPG are significant to p<0.05.
Discussion
We have previously described a method for the overexpression of murine CFTR 14 . Since the publication of that protocol, we have expressed and purified several different orthologs of CFTR using the same system. All orthologs tested so far purified well in the LPG detergent, whilst the DDM purification showed more variation across different orthologs (data not shown). This flexibility illustrates the strength of the yeast approach: it is possible to screen many constructs with relative rapidity in order to select one for a particular purpose.
Washing the yeast microsomes with buffer containing 1 M NaCl prior to solubilization with DDM results in a cleaner microsome preparation and reduces contaminants at later stages. This step is unnecessary in the LPG protocol as the final CFTR sample is >90% pure without the microsome wash. Furthermore, purification in DDM requires several alterations to the buffers for solubilization and purification, namely the addition of extra glycerol and salt. Together, these additions considerably increased the binding of the DDM-solubilized protein to the column.
The DDM purification methodology has scope for improvement, in particular the removal of a 40 kDa major contaminant that, judged by mass spectrometry, is due to the yeast ribosomal subunit L3, which appears to have an inherent affinity for the nickel resin. There is no obvious polyHis sequence in the L3 protein, but examination of its 3D structure when bound to the ribosome (PDB = 1FFK) shows that the folded L3 subunit has a potential polyHis cluster. That this band is less problematic in LPG-purified material may be due to the harsher LPG detergent.
Though the purification in DDM appears to be poorer than that in LPG, milder detergents such as DDM may be more compatible with functional and structural analyses and have already been used in several X-ray crystallographic studies of membrane proteins [15] [16] [17] [18] [19] [20] [21] . Furthermore, our results indicated that the use of LPG leads to loss of ATPase function in CFTR relative to purification in DDM. Hence we would recommend the LPG-based purification protocol for the generation of CFTR where the purity is crucial, for example in applications such as the characterization of post-translational modifications, or in the generation of antibodies, the LPG-based protocol would be chosen. On the other hand in applications where the activity and fully native state of the protein is essential, we would propose the DDM-based protocol as a better option.
To conclude, this protocol describes a reproducible method for the isolation of CFTR in the zwitterionic detergent LPG-14 or the non-ionic detergent DDM. As such it indicates a greater range of purification conditions for CFTR than have previously been reported [10] [11] [12] [13] . In addition milligram quantities of purified CFTR can be obtained using these procedures when combined with a high volume yeast growth system such as a 20 L fermenter and a high capacity cell harvesting system such as a 6 L low speed centrifuge rotor. The CFTR obtained has a cleavable GFP tag which allows easy monitoring of the protein in various biochemical and biophysical assays.
